[A report of initial clinical use of left ventricular assist system with left ventricular inflow cannula for acute myocardial infarction].
Previous clinical results of left ventricular assist system (LVAS) therapy for cardiogenic shock due to acute myocardial infarction (AMI) are still unacceptable. Japanese LVAS was designed for left atrial inflow cannulation. However, to obtain higher initial LVAS flow and more decompression of left ventricular (LV) cavity and to avoid thromboembolic event, LV inflow cannulation is a preferable procedure. Therefore, LV inflow cannula for Japanese LVAS (Toyobo) was developed. We treated three AMI cases with Toyobo-LVAS using the new LV inflow cannula. All patients were in cardiogenic shock status since broad antero-septal AMI and treated with percutaneous cardio-pulmonary support before the LVAS installation. The LVAS was effective for recovery from cardiogenic shock status and multiple organ failure. Two patients died because of serious LVAS associated complications such as bleeding (case 1, 8 days) and cerebral thromboembolism (case 2, 45 days). One of them was assisted for 202 days and underwent second operation. Sixty days after removal of LVAS, the patient died due to sepsis. The technique of LV inflow cannulation is improved through our experiences. However, our result suggests that renovation of the regimen for anti-coagulation and anti-septic therapy are necessary.
Ogiwara
M
M
Division of Cardiac Surgery, Department of Surgery, Saitama Medical Center, Saitama Medical School, Kawagoe, Japan.
Kyo
S
S
Asano
H
H
Tanabe
H
H
Yokote
Y
Y
Gojo
S
S
Yamamoto
S
S
Omoto
R
R
D000368:Aged; D006353:Heart-Assist Devices; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications*; D012770:Shock, Cardiogenic / Q000628:therapy*